Summary

The Middle East and Africa flow cytometry market is expected to reach USD 163.04 million by 2032 from USD 79.48 million in 2024, growing at a CAGR of 9.4% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Flow Cytometry Market, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceuticals and Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, CRO, Blood Bank, CMO & CDMO, Forensic Laboratories, and Others), Distribution Channel (Retail Sales and Direct Tenders), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and Rest of Middle East & Africa) - Industry Trends & Forecast To 2032

Overview of Middle East and Africa Flow Cytometry Market Dynamics:

Driver
• Rising Prevalence of Chronic Diseases
Restrain

• High Cost of Flow Cytometry Instruments

Opportunity

• Increase in Adoption of Flow Cytometry Techniques in Research and Academia

Market Players:

The key market players operating in the Middle East and Africa flow cytometry market are listed below:

• BD
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Bennubio Inc.
• Enzo Biochem Inc.
• Apogee Flow Systems Ltd.
• Beckman Coulter, Inc.
• Coherent Corp.
• Cell Signaling Technology, Inc.
• Cytek Biosciences
• Biomérieux
• Cytonome/ST LLC

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 75
1.1 OBJECTIVES OF THE STUDY 75
1.2 MARKET DEFINITION 75
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET 75
1.4 CURRENCY AND PRICING 77
1.5 LIMITATIONS 77
1.6 MARKETS COVERED 77
2 MARKET SEGMENTATION 80
2.1 MARKETS COVERED 80
2.2 GEOGRAPHICAL SCOPE 81
2.3 YEARS CONSIDERED FOR THE STUDY 82
2.4 DBMR TRIPOD DATA VALIDATION MODEL 83
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 86
2.6 MULTIVARIATE MODELLING 87
2.7 DBMR MARKET POSITION GRID 88
2.8 VENDOR SHARE ANALYSIS 89
2.9 SECONDARY SOURCES 90
2.10 ASSUMPTIONS 90
3 EXECUTIVE SUMMARY 91
4 PREMIUM INSIGHTS 96
4.1 PESTAL ANALYSIS 97
4.2 PORTERS FIVE FORCES ANALYSIS 98
5 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET: REGULATIONS 99
6 MARKET OVERVIEW 101
6.1 DRIVERS 103
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 103
6.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 104
6.1.3 GROWING USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 105
6.1.4 GROWING RESEARCH FUNDING 106
6.2 RESTRAINTS 107
6.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 107
6.2.2 LIMITATIONS OF FLOW CYTOMETRY 107
6.3 OPPORTUNITIES 109
6.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 109
6.3.2 RISING DEVELOPMENT OF PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 109
6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 110
6.4 CHALLENGES 111
6.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 111
6.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 111
7 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY PRODUCT 113
7.1 OVERVIEW 114
7.2 REAGENTS AND CONSUMABLES 117
7.2.1 DYE 118
7.2.2 ANTIBODIES 118
7.2.3 BEADS 118
7.2.4 OTHERS 118
7.3 FLOW CYTOMETRY INSTRUMENTS 118
7.3.1 CELL ANALYZERS 120
7.3.1.1 CELL ANALYZERS, BY TYPE 120
7.3.1.1.1 IMAGING FLOW CYTOMETERS 120
7.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 120
7.3.1.2 CELL ANALYZERS, BY RANGE 121
7.3.1.2.1 HIGH-RANGE CELL ANALYZERS 121
7.3.1.2.2 MID-RANGE CELL ANALYZERS 121
7.3.1.2.3 LOW-RANGE CELL ANALYZERS 121
7.3.1.3 CELL ANALYZERS, BY MODALITY 121
7.3.1.3.1 BENCHTOP 122
7.3.1.3.2 STANDALONE 122
7.3.2 CELL SORTERS 122
7.3.2.1 BENCHTOP 122
7.3.2.2 STANDALONE 122
7.3.3 CELL SORTERS 122
7.3.3.1 HIGH-RANGE CELL ANALYZERS 123
7.3.3.2 MID-RANGE CELL ANALYZERS 123
7.3.3.3 LOW-RANGE CELL ANALYZERS 123
7.4 ACCESSORIES 124
7.4.1 FILTERS 125
7.4.2 DETECTORS 125
7.4.3 OTHERS 125
7.5 SERVICES 126
7.6 SOFTWARE 126
8 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 127
8.1 OVERVIEW 128
8.2 CELL-BASED FLOW CYTOMETRY 131
8.2.1 FLOW CYTOMETRY INSTRUMENTS 132
8.2.2 REAGENTS & CONSUMABLES 132
8.2.3 ACCESSORIES 132
8.3 BEAD-BASED FLOW CYTOMETRY 132
8.3.1 FLOW CYTOMETRY INSTRUMENTS 132
8.3.2 REAGENTS & CONSUMABLES 132
8.3.3 ACCESSORIES 132
9 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY APPLICATION 133
9.1 OVERVIEW 134
9.2 RESEARCH APPLICATIONS 137
9.2.1 CELL CYCLE ANALYSIS 138
9.2.2 CELL SORTING/SCREENING 138
9.2.3 CELL TRANSFECTION/VIABILITY 138
9.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 138
9.2.4.1 DRUG DISCOVERY 138
9.2.4.2 STEM CELL RESEARCH 138
9.2.4.3 IN VITRO TOXICITY TESTING 138
9.2.5 IMMUNOLOGY 139
9.2.6 APOPTOSIS 139
9.2.7 CELL COUNTING 139
9.2.8 OTHERS 139
9.3 CLINICAL APPLICATIONS 139
9.3.1 HAEMATOLOGY 140
9.3.2 CANCER 140
9.3.3 IMMUNODEFICIENCY DISEASES 140
9.3.4 ORGAN TRANSPLANTATION 140
9.3.5 OTHER CLINICAL APPLICATION 140
9.4 INDUSTRIAL APPLICATIONS 140
10 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 141
10.1 OVERVIEW 142
10.2 RETAIL SALES 145
10.2.1 OFFLINE 145
10.2.2 ONLINE 145
10.3 DIRECT TENDERS 146
11 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY END USER 147
11.1 OVERVIEW 148
11.2 PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES 151
11.3 ACADEMIC & RESEARCH INSTITUTES 152
11.4 HOSPITALS 152
11.5 CLINICAL TESTING LABORATORIES 153
11.6 CRO 153
11.7 BLOOD BANK 154
11.8 CMO & CDMO 154
11.9 FORENSIC LABORATORIES 155
11.10 OTHERS 155
12 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET, BY REGION 156
12.1 MIDDLE EAST AND AFRICA 158
12.1.1 SOUTH AFRICA 168
12.1.2 SAUDI ARABIA 177
12.1.3 U.A.E. 186
12.1.4 EGYPT 194
12.1.5 KUWAIT 202
12.1.6 ISRAEL 210
12.1.7 REST OF MIDDLE EAST AND AFRICA 218
13 MIDDLE EAST AND AFRICA FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 219
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 SWOT ANALYSIS 220
15 COMPANY PROFILES 221
15.1 BD 221
15.1.1 COMPANY SNAPSHOT 221
15.1.2 REVENUE ANALYSIS 221
15.1.3 COMPANY SHARE ANALYSIS 222
15.1.4 PRODUCT PORTFOLIO 222
15.1.5 RECENT DEVELOPMENT 225
15.2 AGILENT TECHNOLOGIES, INC. 226
15.2.1 COMPANY SNAPSHOT 226
15.2.2 REVENUE ANALYSIS 226
15.2.3 COMPANY SHARE ANALYSIS 227
15.2.4 PRODUCT PORTFOLIO 227
15.2.5 RECENT DEVELOPMENT 229
15.3 THERMO FISHER SCIENTIFIC INC 230
15.3.1 COMPANY SNAPSHOT 230
15.3.2 REVENUE ANALYSIS 231
15.3.3 COMPANY SHARE ANALYSIS 231
15.3.4 PRODUCT PORTFOLIO 231
15.3.5 RECENT DEVELOPMENT 234
15.4 BIO-RAD LABORATORIES, INC. 235
15.4.1 COMPANY SNAPSHOT 235
15.4.2 REVENUE ANALYSIS 235
15.4.3 COMPANY SHARE ANALYSIS 236
15.4.4 PRODUCT PORTFOLIO 236
15.4.5 RECENT DEVELOPMENT 237
15.5 SARTORIUS AG 238
15.5.1 COMPANY SNAPSHOT 238
15.5.2 REVENUE ANALYSIS 239
15.5.3 COMPANY SHARE ANALYSIS 239
15.5.4 PRODUCT PORTFOLIO 239
15.5.5 RECENT DEVELOPMENT 241
15.6 APOGEE FLOW SYSTEMS LTD. 242
15.6.1 COMPANY SNAPSHOT 242
15.6.2 PRODUCT PORTFOLIO 242
15.6.3 RECENT DEVELOPMENT 242
15.7 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 243
15.7.1 COMPANY SNAPSHOT 243
15.7.2 REVENUE ANALYSIS 243
15.7.3 PRODUCT PORTFOLIO 244
15.7.4 RECENT DEVELOPMENT 245
15.8 BIOMÉRIEUX 247
15.8.1 COMPANY SNAPSHOT 247
15.8.2 REVENUE ANALYSIS 247
15.8.3 PRODUCT PORTFOLIO 248
15.8.4 RECENT DEVELOPMENT 248
15.9 BIOLEGEND, INC. 249
15.9.1 COMPANY SNAPSHOT 249
15.9.2 PRODUCT PORTFOLIO 249
15.9.3 RECENT DEVELOPMENT 249
15.10 BENNUBIO INC 250
15.10.1 COMPANY SNAPSHOT 250
15.10.2 PRODUCT PORTFOLIO 250
15.10.3 RECENT DEVELOPMENT 250
15.11 COHERENT CORP. 251
15.11.1 COMPANY SNAPSHOT 251
15.11.2 REVENUE ANALYSIS 251
15.11.3 PRODUCT PORTFOLIO 252
15.11.4 RECENT DEVELOPMENT 252
15.12 CYTONOME/ST, LLC 253
15.12.1 COMPANY SNAPSHOT 253
15.12.2 PRODUCT PORTFOLIO 253
15.12.3 RECENT DEVELOPMENTS 254
15.13 CYTOBUOY 255
15.13.1 COMPANY SNAPSHOT 255
15.13.2 PRODUCT PORTFOLIO 255
15.13.3 RECENT DEVELOPMENT 256
15.14 CELL SIGNALING TECHNOLOGY, INC 257
15.14.1 COMPANY SNAPSHOT 257
15.14.2 PRODUCT PORTFOLIO 257
15.14.3 RECENT DEVELOPMENT 258
15.15 CYTEK BIOSCIENCES 259
15.15.1 COMPANY SNAPSHOT 259
15.15.2 PRODUCT PORTFOLIO 259
15.15.3 RECENT DEVELOPMENT 260
15.16 DIASORIN S.P.A. 261
15.16.1 COMPANY SNAPSHOT 261
15.16.2 REVENUE ANALYSIS 261
15.16.3 PRODUCT PORTFOLIO 262
15.16.4 RECENT DEVELOPMENT 262
15.17 ELABSCIENCE BIONOVATION INC. 263
15.17.1 COMPANY SNAPSHOT 263
15.17.2 PRODUCT PORTFOLIO 263
15.17.3 RECENT DEVELOPMENT 264
15.18 ENZO BIOCHEM, INC 265
15.18.1 COMPANY SNAPSHOT 265
15.18.2 REVENUE ANALYSIS 265
15.18.3 PRODUCT PORTFOLIO 266
15.18.4 RECENT DEVELOPMENT 267
15.19 MILTENYI BIOTEC AND/OR ITS AFFILIATES 268
15.19.1 COMPANY SNAPSHOT 268
15.19.2 PRODUCT PORTFOLIO 268
15.19.3 RECENT DEVELOPMENT 270
15.20 MERCK KGAA 271
15.20.1 COMPANY SNAPSHOT 271
15.20.2 REVENUE ANALYSIS 271
15.20.3 PRODUCT PORTFOLIO 272
15.20.4 RECENT DEVELOPMENT 273
15.21 NANOCELLECT BIOMEDICAL 274
15.21.1 COMPANY SNAPSHOT 274
15.21.2 PRODUCT PORTFOLIO 274
15.21.3 RECENT DEVELOPMENTS 275
15.22 NEOGENOMICS LABORATORIES 277
15.22.1 COMPANY SNAPSHOT 277
15.22.2 REVENUE ANALYSIS 278
15.22.3 PRODUCT PORTFOLIO 278
15.22.4 RECENT DEVELOPMENT 278
15.23 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 279
15.23.1 COMPANY SNAPSHOT 279
15.23.2 PRODUCT PORTFOLIO 279
15.23.3 RECENT DEVELOPMENTS 280
15.24 ORLFO TECHNOLOGIES 281
15.24.1 COMPANY SNAPSHOT 281
15.24.2 PRODUCT PORTFOLIO 281
15.24.3 RECENT DEVELOPMENT 281
15.25 STRATEDIGM, INC 282
15.25.1 COMPANY SNAPSHOT 282
15.25.2 PRODUCT PORTFOLIO 282
15.25.3 RECENT DEVELOPMENTS 283
15.26 SONY BIOTECHNOLOGY INC 284
15.26.1 COMPANY SNAPSHOT 284
15.26.2 PRODUCT PORTFOLIO 284
15.26.3 RECENT DEVELOPMENT 286
15.27 SYSMEX ASIA PACIFIC PTE LTD (PART OF SYSMEX CORPORATION) 287
15.27.1 COMPANY SNAPSHOT 287
15.27.2 REVENUE ANALYSIS 287
15.27.3 PRODUCT PORTFOLIO 288
15.27.4 RECENT DEVELOPMENT 289
15.28 TAKARA BIO INC. 290
15.28.1 COMPANY SNAPSHOT 290
15.28.2 PRODUCT PORTFOLIO 290
15.28.3 RECENT DEVELOPMENT 291
15.29 UNION BIOMETRICA, INC. 292
15.29.1 COMPANY SNAPSHOT 292
15.29.2 PRODUCT PORTFOLIO 292
15.29.3 RECENT DEVELOPMENTS 293
16 QUESTIONNAIRE 295
17 RELATED REPORTS 298